Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
medicines.ie | Reliable & Accurate Online Medicines Information | Home page
Home Medicines Active Ingredients Companies DHPC Advanced Search Side Effect Reporting
Login
  • Home
  • Active Ingredients
  • Adalimumab

Adalimumab

Medicine Status Monitoring SPC PIL XPIL Legal Category Active Ingredient(s) Company
AMGEVITA pre-filled pen
No Recent Update
SPC PIL No A
Adalimumab
Amgen Ireland Ltd
AMGEVITA pre-filled syringe-pre-filled pen (High Concentration)
No Recent Update
SPC PIL No B
Adalimumab
Amgen Ireland Ltd
AMGEVITA prefilled syringe
No Recent Update
SPC PIL No A
Adalimumab
Amgen Ireland Ltd
hefiya
Adalimumab
Sandoz GmbH
hukyndra
Adalimumab
STADA Arzneimittel AG
Humira 20 mg solution for injection in pre-filled syringe
No Recent Update
SPC PIL No A
Adalimumab
AbbVie Limited
Humira 40 mg solution for injection in pre-filled syringe
No Recent Update
SPC PIL No A
Adalimumab
AbbVie Limited
Humira 40mg solution for injection in pre-filled pen
No Recent Update
SPC PIL No A
Adalimumab
AbbVie Limited
Humira 80 mg solution for injection in pre-filled pen
No Recent Update
SPC PIL No A
Adalimumab
AbbVie Limited
Idacio 40 mg solution for injection in Pre-filled Pen (Auto Injector)
No Recent Update
SPC PIL No A
Adalimumab
Fresenius Kabi Ltd
Imraldi 40 mg solution for injection in pre-filled syringe
No Recent Update
SPC PIL Yes A
Adalimumab
Biogen Biosimilar
Imraldi 40mg solution for injection in pre-filled pen
No Recent Update
SPC PIL Yes A
Adalimumab
Biogen Biosimilar
libmyris
Adalimumab
STADA Arzneimittel AG
YUFLYMA pre-filled pen & syringe (high concentration)
No Recent Update
SPC PIL No A
Adalimumab
Celltrion Healthcare Ireland Ltd.

Brought to you by

Irish Pharmaceutical Healthcare Association | Home pageIrish Pharmaceutical Healthcare Association | Home page

About

  • Help
  • About
  • Contact Us

Legal

  • Privacy Statement
  • Terms & Conditions
  • Accessibility

Search

  • Medicines
  • Active Ingredients
  • Companies

Award

Pharma Industry Awards 2020, Innovation of the Year, 2nd Place
Designed by eConcept Web Solutions
Direct Healthcare Professional Communications
The Summary of Product Characteristics (SPC) is a specific document, the wording of which has been agreed with the regulatory authority as part of the medicine approval process. It is required before any medicine is allowed on the market in Europe. It is designed to assist doctors and pharmacists in prescribing and supplying the product.
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
This medicine and its document have not been updated in the last 30 days.
''Company'' may refer to either the Marketing Authorization Holder (MAH), the company responsible for marketing the product in Ireland and/or responsible for uploading documents pertaining to the product onto medicines.ie. To determine the MAH, please consult the actual submitted documents.
Product subject to medical prescription which may not be renewed (A)
Product subject to medical prescription which may be renewed (B)
Black Inverted Triangle: This medicinal product is subject to additional monitoring.